Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo

被引:39
|
作者
Riad, Alexander [1 ]
Westermann, Dirk [1 ]
Escher, Felicitas [1 ]
Becher, Peter M. [1 ]
Savvatis, Konstantinos [1 ]
Lettau, Olga [1 ]
Heimesaat, Markus M. [3 ]
Bereswill, Stefan [3 ]
Volk, Hans D. [2 ,4 ]
Schultheiss, Heinz P. [1 ]
Tschoepe, Carsten [1 ,2 ]
机构
[1] Charite, Dept Cardiol, D-12203 Berlin, Germany
[2] Charite, Berlin Brandenberg Ctr Regenerat Therapies, Campus Virchow Klinikum, D-13353 Berlin, Germany
[3] Charite, Dept Microbiol, D-13353 Berlin, Germany
[4] Charite, Dept Med Immunol, D-13353 Berlin, Germany
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2010年 / 298卷 / 06期
关键词
heart failure; inflammation; innate immunity; LEFT-VENTRICULAR FUNCTION; EXPERIMENTAL DIABETIC CARDIOMYOPATHY; DOXORUBICIN-INDUCED CARDIOMYOPATHY; ISCHEMIA-REPERFUSION INJURY; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-4; AUTOIMMUNE MYOCARDITIS; HEART-FAILURE; MATRIX METALLOPROTEINASES; CARDIAC-HYPERTROPHY;
D O I
10.1152/ajpheart.01188.2009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Riad A, Westermann D, Escher F, Becher PM, Savvatis K, Lettau O, Heimesaat MM, Bereswill S, Volk HD, Schultheiss HP, Tschope C. Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo. Am J Physiol Heart Circ Physiol 298: H2024-H2031, 2010. First published March 12, 2010; doi:10.1152/ajpheart.01188.2009.-Toll-like receptor 9 (TLR9) is a member of the innate immune system and has been shown to influence myocardial function, but its role in myocarditis is hitherto unknown. We therefore investigated whether or not TLR9 plays a role in this disease in coxsackievirus B3 (CVB3)-induced myocarditis in mice. Left ventricular (LV) function, cardiac immune cell infiltration, virus mRNA, and components of the TLR9 downstream pathway were investigated in TLR9-deficient [knockout (KO)] and wild-type (WT) mice after infection with CVB3. Murine cardiac TLR9 expression was significantly increased in WT mice with acute CVB3 infection but not in WT mice with chronic myocarditis. Furthermore, in the acute phase of CVB3-induced myocarditis, CVB3-infected KO mice displayed improved LV function associated with reduced cardiac inflammation indexed by reduced amounts of immune cells compared with CVB3-infected WT mice. In contrast, in the chronic phase, LV function and inflammation were not seen to differ among the infected groups. The cardioprotective effects due to TLR9 deficiency were associated with suppression of the TLR9 downstream pathway as indexed by reduced cardiac levels of the adapter protein myeloid differentiation factor (MyD)-88 and the proinflammatory cytokine TNF-alpha. In addition, TLR9 deficiency led to an activation of the antiviral cytokine interferon-beta in the heart as a result from viral infection. In conclusion, the MyD88/TNF-alpha axis due to TLR9 activation in the heart contributes the development of acute myocarditis but not of chronic myocarditis.
引用
收藏
页码:H2024 / H2031
页数:8
相关论文
共 50 条
  • [21] Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis
    Cai, Zhejun
    Shen, Li
    Ma, Hong
    Yang, Jin
    Yang, Du
    Chen, Han
    Wei, Jia
    Lu, Qiulun
    Wang, Dao Wen
    Xiang, Meixiang
    Wang, Jian'an
    CIRCULATION-HEART FAILURE, 2015, 8 (04) : 809 - U246
  • [22] ROLE OF S100A8 AND S100A9 ALARMINS IN COXSACKIEVIRUS B3-INDUCED MYOCARDITIS
    Tschoepe, Carsten
    Mueller, Irene
    Vogl, Thomas
    Pieske, Burkert
    Van Linthout, Sophie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1398 - 1398
  • [23] IL-9 inhibits viral replication in coxsackievirus B3-induced myocarditis (vol 7, 409, 2016)
    Yu, Miao
    Long, Qi
    Li, Huan-Huan
    Liang, Wei
    Liao, Yu-Hua
    Yuan, Jing
    Cheng, Xiang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] Expression of CD80 and CD86 on B cells during coxsackievirus B3-induced acute myocarditis
    Huang, Yanlan
    Wei, Bin
    Gao, Xingcui
    Deng, Yan
    Wu, Weifeng
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 44 (04) : 364 - 369
  • [25] AAV9 vector-mediated expression of a soluble coxsackievirus-adenovirus receptor inhibits coxsackievirus B3-induced chronic myocarditis in a therapeutic approach in mice
    Pinkert, S.
    Klopfleisch, R.
    Dieringer, B.
    Schmidtke, M.
    Savvatis, K.
    Fechner, H.
    HUMAN GENE THERAPY, 2015, 26 (10) : A106 - A107
  • [26] Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis
    Schmidtke, M
    Glück, B
    Merkle, I
    Hofmann, P
    Stelzner, A
    Gemsa, D
    JOURNAL OF MEDICAL VIROLOGY, 2000, 61 (04) : 518 - 526
  • [27] MMP13 prevents cardiac injury and left ventricular dysfunction in Coxsackievirus B3-induced acute myocarditis
    Becher, P. M.
    Lindner, D.
    Savvatis, K.
    Schultheiss, H. P.
    Tschoepe, C.
    Westermann, D.
    EUROPEAN HEART JOURNAL, 2013, 34 : 623 - 623
  • [28] Human Cardiac-Derived Adherent Proliferating Cells Reduce Murine Acute Coxsackievirus B3-Induced Myocarditis
    Miteva, Kapka
    Haag, Marion
    Peng, Jun
    Savvatis, Kostas
    Becher, Peter Moritz
    Seifert, Martina
    Warstat, Katrin
    Westermann, Dirk
    Ringe, Jochen
    Sittinger, Michael
    Schultheiss, Heinz-Peter
    Tschoepe, Carsten
    Van Linthout, Sophie
    PLOS ONE, 2011, 6 (12):
  • [29] Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis
    Li Yue-Chun
    Luo Qin
    Ge Li-Sha
    Chen Yi-He
    Zhou Na-Dan
    Zhang Teng
    Guan Xue-Qiang
    Lin Jia-Feng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 431 (03) : 450 - 455
  • [30] Pathogenic role of S100A8 and S100A9 alarmins in Coxsackievirus B3-induced myocarditis
    Mueller, I.
    Van Linthout, S.
    Vogl, T.
    Pieske, B.
    Tschoepe, C.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1365 - 1365